We identified a metabolite, ALA, that effectively alleviated T. gondii-induced lethal colitis and showed that its therapeutic effect was mediated by inhibiting the secretion of pro-inflammation cytokines through the inhibition of the MyD88/NF-κB pathway. This evidence concerns the gene NFKB1 and colitis.